MIRA Pharmaceuticals(us:MIRA)

1.29

+10.26%

Updated on 2025-06-24

Open:1.17
Close:1.29
High:1.30
Low:1.17
Prev Close:1.17
Volume:196146.00
Turnover:241594.00
Turnover Ratio:1.16%
Shares:16.92M
MarketCap:21.83M

About

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.
Address:1200 Brickell Avenue,Suite 1950 1183

Market Movers